ESR1 and breast carcinoma: Although previous studies (6,25) have suggested that it is difficult to determine which checkpoint Tan I targets, the present study demonstrated that Tan I significantly increased the potency of cell cycle arrest at the S phase in human ER-positive and -negative human breast cancer cells.